BamSEC and AlphaSense Join Forces
Learn More

Aptalis Pharma Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.30
from 10-Q/A 125 pages December 28, 2011 Strakan International S.À R.L. Prostrakan Inc. (For the Purposes of Sections 5.1 and 11.1.2) – And – Aptalis Pharma US, Inc. Commercialization and License Agreement
12/34/56
EX-10.31
from 10-Q 34 pages Supply Agreement by and Between Strakan International S.À R.L. and Aptalis Pharma US, Inc. Date: December 28, 2011
12/34/56
EX-10.30
from 10-Q 125 pages December 28, 2011 Strakan International S.À R.L. Prostrakan Inc. (For the Purposes of Sections 5.1 and 11.1.2) – And – Aptalis Pharma US, Inc. Commercialization and License Agreement
12/34/56
EX-10.19
from 10-K 22 pages Amended and Restated Aptalis Holdings Inc. Management Equity Incentive Plan
12/34/56
EX-10.15
from 10-K 19 pages Confidential Employment Agreement
12/34/56
EX-10.14
from 10-K 4 pages Material contract
12/34/56
EX-10.13
from 10-K 6 pages Material contract
12/34/56
EX-10.1
from 8-K 73 pages Share Purchase Agreement by and Among Axcan Holdings Inc., Axcan Pharma Holding B.V. and Eurand N.V. Dated as of November 30, 2010
12/34/56
EX-10.24
from 10-K 5 pages December 16, 2009 Axcan Holdings Inc. 597 Boulevard Laurier Mont-Saint-Hilaire, Qc J3h 6c4 Re: Advancement and Indemnification Rights
12/34/56
EX-10.1
from 10-Q 3 pages Supplement No. 1, Dated as of December 5, 2008, to the Guaranty Dated as of February 25, 2008 Among Axcan Midco Inc. (“Holdings”), Axcan Intermediate Holdings Inc. (The “Parent Borrower”), Axcan US Partnership 1 LP, (The “Co-Borrower”), Certain Other Subsidiaries of Axcan Intermediate Holdings Inc. From Time to Time Party Thereto and Bank of America, N.A., as Administrative Agent
12/34/56
EX-10.23
from 10-K 10 pages Axcan Holdings Inc. Employee Long Term Incentive Plan Adopted June 3, 2008
12/34/56
EX-10.18
from S-4/A 8 pages Incentive Compensation Plan
12/34/56
EX-10.17
from S-4/A 31 pages Axcan Holdings Inc. Management Equity Incentive Plan Adopted April 15, 2008
12/34/56
EX-10.16
from S-4/A 17 pages Axcan Pharma Inc. Severance Pay Plan
12/34/56
EX-10.15
from S-4/A 6 pages October 5, 2007 Confidential Mr. Nicholas Franco 21 Rue Boulainvilliers 75016 Paris Dear Nicholas: We Are Pleased to Confirm in Writing the Terms and Conditions of Your Position as Président Directeur Général of Our French Subsidiary, Axcan Pharma SA (The “Company”), as Such Terms and Conditions Are Further Set Out in This Letter (“Letter Agreement”). Should You Agree With the Terms of This Letter Agreement, Your Appointment Would Become Effective as Soon as It Is Formally Instrumented in a Decision of the Company’s Competent Corporate Body (The “Effective Date”). a Copy of the Company’s By-Laws Is Attached as Exhibit 1 to This Letter Agreement (The “By-Laws”)
12/34/56
EX-10.21
from S-4 7 pages Penny Option Grant Agreement
12/34/56
EX-10.20
from S-4 7 pages Restricted Stock Unit Grant Agreement
12/34/56
EX-10.19
from S-4 7 pages Restricted Stock Unit Grant Agreement
12/34/56
EX-10.18
from S-4 22 pages Form of Axcan Holdings Inc. Management Stockholders’ Agreement
12/34/56
EX-10.14
from S-4 16 pages Employment Agreement
12/34/56